Published in Vaccine Weekly, July 7th, 1997
The clinical trials, to be conducted at several clinical sites around the country, are designed to establish the safety and immunogenicity of this vaccine in infants and children.
In the clinical program, the DTaP-IPV vaccine will be administered to infants at two, four,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.